---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-024217"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T13:18:00.933172+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Foghorn Therapeutics files investor presentation; no specific facts available in filing text

## Summary
- Form 8-K furnished under Item 7.01; presentation dated May 20, 2024.
- Presentation tagged 'Unique biology, Precision therapeutics, Broad impact'.
- No quantitative data, pipeline updates, or financial guidance provided in the filing.
- Presentation available as Exhibit 99.1 but its content is not extracted in this filing.

## SEC filing metadata
- accession: 0001628280-24-024217
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828024024217/0001628280-24-024217-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828024024217/fhtx-20240520.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-024217
- JSON: https://secwatch.observer/filing/0001628280-24-024217.json
- Plain text: https://secwatch.observer/filing/0001628280-24-024217.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.